Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Cancer Cell. 2011 Sep 13;20(3):289-99. doi: 10.1016/j.ccr.2011.08.007.
We investigated the potential of in-depth quantitative proteomics to reveal plasma protein signatures that reflect lung tumor biology. We compared plasma protein profiles of four mouse models of lung cancer with profiles of models of pancreatic, ovarian, colon, prostate, and breast cancer and two models of inflammation. A protein signature for Titf1/Nkx2-1, a known lineage-survival oncogene in lung cancer, was found in plasmas of mouse models of lung adenocarcinoma. An EGFR signature was found in plasma of an EGFR mutant model, and a distinct plasma signature related to neuroendocrine development was uncovered in the small-cell lung cancer model. We demonstrate relevance to human lung cancer of the protein signatures identified on the basis of mouse models.
我们研究了深度定量蛋白质组学揭示反映肺癌生物学的血浆蛋白特征的潜力。我们比较了四种肺癌小鼠模型与胰腺癌、卵巢癌、结肠癌、前列腺癌和乳腺癌模型以及两种炎症模型的血浆蛋白图谱。在肺腺癌小鼠模型的血浆中发现了 Titf1/Nkx2-1(一种已知的肺癌谱系存活致癌基因)的蛋白特征。在 EGFR 突变模型的血浆中发现了 EGFR 特征,在小细胞肺癌模型中发现了与神经内分泌发育相关的独特血浆特征。我们证明了基于小鼠模型鉴定的蛋白质特征与人类肺癌的相关性。